WST vs. ALGN, COO, XRAY, MMSI, HAE, NEOG, QDEL, ICUI, STAA, and ATRI
Should you be buying West Pharmaceutical Services stock or one of its competitors? The main competitors of West Pharmaceutical Services include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Merit Medical Systems (MMSI), Haemonetics (HAE), Neogen (NEOG), QuidelOrtho (QDEL), ICU Medical (ICUI), STAAR Surgical (STAA), and Atrion (ATRI). These companies are all part of the "health care supplies" industry.
West Pharmaceutical Services (NYSE:WST) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.
West Pharmaceutical Services presently has a consensus price target of $435.20, suggesting a potential upside of 36.06%. Align Technology has a consensus price target of $351.00, suggesting a potential upside of 37.27%. Given Align Technology's higher probable upside, analysts plainly believe Align Technology is more favorable than West Pharmaceutical Services.
West Pharmaceutical Services has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.62, indicating that its stock price is 62% more volatile than the S&P 500.
West Pharmaceutical Services has a net margin of 19.42% compared to Align Technology's net margin of 11.80%. West Pharmaceutical Services' return on equity of 20.57% beat Align Technology's return on equity.
93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.5% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 0.6% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Align Technology received 503 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 69.61% of users gave Align Technology an outperform vote while only 55.74% of users gave West Pharmaceutical Services an outperform vote.
West Pharmaceutical Services has higher earnings, but lower revenue than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.
In the previous week, Align Technology had 7 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 13 mentions for Align Technology and 6 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.70 beat Align Technology's score of 0.90 indicating that West Pharmaceutical Services is being referred to more favorably in the media.
Summary
West Pharmaceutical Services beats Align Technology on 10 of the 18 factors compared between the two stocks.
Get West Pharmaceutical Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding WST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
West Pharmaceutical Services Competitors List
Related Companies and Tools
